1. Home
  2. EVAX vs LDWY Comparison

EVAX vs LDWY Comparison

Compare EVAX & LDWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVAX
  • LDWY
  • Stock Information
  • Founded
  • EVAX 2008
  • LDWY 1990
  • Country
  • EVAX Denmark
  • LDWY United States
  • Employees
  • EVAX N/A
  • LDWY N/A
  • Industry
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • LDWY Advertising
  • Sector
  • EVAX Health Care
  • LDWY Consumer Discretionary
  • Exchange
  • EVAX Nasdaq
  • LDWY Nasdaq
  • Market Cap
  • EVAX 8.7M
  • LDWY 8.2M
  • IPO Year
  • EVAX 2021
  • LDWY 1991
  • Fundamental
  • Price
  • EVAX $2.61
  • LDWY $4.12
  • Analyst Decision
  • EVAX Strong Buy
  • LDWY
  • Analyst Count
  • EVAX 3
  • LDWY 0
  • Target Price
  • EVAX $33.33
  • LDWY N/A
  • AVG Volume (30 Days)
  • EVAX 6.9M
  • LDWY 4.5K
  • Earning Date
  • EVAX 03-26-2025
  • LDWY 03-31-2025
  • Dividend Yield
  • EVAX N/A
  • LDWY N/A
  • EPS Growth
  • EVAX N/A
  • LDWY N/A
  • EPS
  • EVAX N/A
  • LDWY N/A
  • Revenue
  • EVAX $3,295,000.00
  • LDWY $31,581,000.00
  • Revenue This Year
  • EVAX $9,039.73
  • LDWY N/A
  • Revenue Next Year
  • EVAX $1.47
  • LDWY N/A
  • P/E Ratio
  • EVAX N/A
  • LDWY N/A
  • Revenue Growth
  • EVAX N/A
  • LDWY N/A
  • 52 Week Low
  • EVAX $2.22
  • LDWY $3.02
  • 52 Week High
  • EVAX $22.50
  • LDWY $6.88
  • Technical
  • Relative Strength Index (RSI)
  • EVAX 40.78
  • LDWY 43.25
  • Support Level
  • EVAX $2.30
  • LDWY $4.13
  • Resistance Level
  • EVAX $2.90
  • LDWY $4.30
  • Average True Range (ATR)
  • EVAX 0.64
  • LDWY 0.20
  • MACD
  • EVAX 0.03
  • LDWY -0.02
  • Stochastic Oscillator
  • EVAX 7.29
  • LDWY 4.02

About EVAX Evaxion Biotech

Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.

About LDWY Lendway Inc. (DE)

Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two Industry Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.

Share on Social Networks: